IL276914A - CSF1R binding factors - Google Patents

CSF1R binding factors

Info

Publication number
IL276914A
IL276914A IL276914A IL27691420A IL276914A IL 276914 A IL276914 A IL 276914A IL 276914 A IL276914 A IL 276914A IL 27691420 A IL27691420 A IL 27691420A IL 276914 A IL276914 A IL 276914A
Authority
IL
Israel
Prior art keywords
binding agents
csf1r binding
csf1r
agents
binding
Prior art date
Application number
IL276914A
Other languages
English (en)
Hebrew (he)
Inventor
William James Jonathan Finlay
Original Assignee
William James Jonathan Finlay
Ultrahuman Twelve Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by William James Jonathan Finlay, Ultrahuman Twelve Ltd filed Critical William James Jonathan Finlay
Publication of IL276914A publication Critical patent/IL276914A/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • C07K16/2866—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against receptors for cytokines, lymphokines, interferons
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/20—Immunoglobulins specific features characterized by taxonomic origin
    • C07K2317/21—Immunoglobulins specific features characterized by taxonomic origin from primates, e.g. man
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/50—Immunoglobulins specific features characterized by immunoglobulin fragments
    • C07K2317/56—Immunoglobulins specific features characterized by immunoglobulin fragments variable (Fv) region, i.e. VH and/or VL
    • C07K2317/565—Complementarity determining region [CDR]
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/50—Immunoglobulins specific features characterized by immunoglobulin fragments
    • C07K2317/56—Immunoglobulins specific features characterized by immunoglobulin fragments variable (Fv) region, i.e. VH and/or VL
    • C07K2317/567—Framework region [FR]
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/90—Immunoglobulins specific features characterized by (pharmaco)kinetic aspects or by stability of the immunoglobulin
    • C07K2317/92—Affinity (KD), association rate (Ka), dissociation rate (Kd) or EC50 value

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Biophysics (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
IL276914A 2018-02-28 2020-08-25 CSF1R binding factors IL276914A (en)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
GBGB1803226.8A GB201803226D0 (en) 2018-02-28 2018-02-28 CSF1R Binding agents
GBGB1810226.9A GB201810226D0 (en) 2018-02-28 2018-06-21 CSF1R binding agents
GBGB1819045.4A GB201819045D0 (en) 2018-02-28 2018-11-22 Csf1r binding agents
PCT/EP2019/055077 WO2019166596A1 (en) 2018-02-28 2019-02-28 Csf1r binding agents

Publications (1)

Publication Number Publication Date
IL276914A true IL276914A (en) 2020-10-29

Family

ID=61903334

Family Applications (1)

Application Number Title Priority Date Filing Date
IL276914A IL276914A (en) 2018-02-28 2020-08-25 CSF1R binding factors

Country Status (10)

Country Link
US (1) US11655300B2 (https=)
EP (1) EP3759137A1 (https=)
JP (1) JP2021514654A (https=)
CN (1) CN111788229A (https=)
AU (1) AU2019228110A1 (https=)
CA (1) CA3091307A1 (https=)
GB (3) GB201803226D0 (https=)
IL (1) IL276914A (https=)
SG (1) SG11202007837RA (https=)
WO (1) WO2019166596A1 (https=)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2023547499A (ja) * 2020-11-06 2023-11-10 ノバルティス アーゲー 抗体Ｆｃ変異体
CN112472790B (zh) * 2020-12-25 2022-12-20 同济大学 小白蛋白的抑制剂在制备预防治疗肥胖以及肥胖导致的疾病产品中的用途
CN119019548B (zh) * 2022-07-05 2025-06-24 东莞市朋志生物科技有限公司 抗甲型流感病毒抗体、检测甲型流感病毒的试剂和试剂盒

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK2262836T3 (da) * 2008-03-14 2016-04-04 Transgene Sa Antistof mod CSF-1R
AR080698A1 (es) * 2010-04-01 2012-05-02 Imclone Llc Anticuerpo o fragmento del mismo que especificamente enlaza la variante de csf -1r humano, composicion farmaceutica que lo comprende, su uso para la manufactura de un medicamento util para el tratamiento de cancer y metodo para determinar si un sujeto es candidato para tratamiento de cancer basado e
MX378336B (es) * 2010-05-04 2025-03-10 Five Prime Therapeutics Inc Anticuerpos que se unen a factor estimulante de colonias 1 (csf1r).
RU2014136332A (ru) * 2012-02-06 2016-03-27 Дженентек, Инк. Композиции и способы применения ингибиторов csf1r
GB201315487D0 (en) * 2013-08-30 2013-10-16 Ucb Pharma Sa Antibodies

Also Published As

Publication number Publication date
CA3091307A1 (en) 2019-09-06
EP3759137A1 (en) 2021-01-06
WO2019166596A1 (en) 2019-09-06
CN111788229A (zh) 2020-10-16
GB201819045D0 (en) 2019-01-09
US20210301026A1 (en) 2021-09-30
GB201803226D0 (en) 2018-04-11
JP2021514654A (ja) 2021-06-17
SG11202007837RA (en) 2020-09-29
GB201810226D0 (en) 2018-08-08
US11655300B2 (en) 2023-05-23
AU2019228110A1 (en) 2020-09-17

Similar Documents

Publication Publication Date Title
IL272643A (en) Binders
GB201802201D0 (en) Binding agents
SG11202103773TA (en) Binding domain
GB201814169D0 (en) Blockchain autonoumous agents
SG11202008246VA (en) Pd1 binding agents
IL268288A (en) Binders
IL277131A (en) PD1 binding factors
IL276914A (en) CSF1R binding factors
GB201804094D0 (en) ERBB3 Binding agents
GB201801634D0 (en) #
GB201808570D0 (en) Binding agents
GB201802595D0 (en) Binding agents
GB201917205D0 (en) Use
GB201916691D0 (en) Use
GB201713296D0 (en) Binding agents
GB201713298D0 (en) Binding agents
GB201820913D0 (en) St
GB201813992D0 (en) St
GB201813486D0 (en) st
GB201813476D0 (en) st
GB201813347D0 (en) St
GB201813206D0 (en) St
GB201701351D0 (en) Binding agents
GB201811251D0 (en) St
GB201809615D0 (en) St